Cell Culture Company

Cell Culture Company is a long-established, private CDMO offering specialized services and technology platforms for the cell therapy and biologics sectors. The company's core expertise lies in mammalian cell culture, supported by its proprietary hollow-fiber perfusion bioreactor systems, which are designed for high-density, continuous cell culture. Operating under ISO 9001:2015 certification, it serves as a strategic partner for research and development, process optimization, and small-to-medium scale production. Its business model is service-based, generating revenue through client contracts for its technical services and system sales.

Hollow-fiber perfusion bioreactor systems for high-density, continuous mammalian cell culture.

Cell Culture Company competes in the fragmented CDMO space, facing competition from global giants (e.g., Lonza, Catalent), large biopharma-focused CDMOs (e.g., Samsung Biologics), and numerous niche service providers. Its differentiation lies in its deep, specialized expertise in hollow-fiber perfusion systems and associated process development.